Literature DB >> 7024090

Evidence concerning insulin activity from the structure of a cross-linked derivative.

J Cutfield, S Cutfield, E Dodson, G Dodson, D Hodgkin, C Reynolds.   

Abstract

The important of crystallographic refinement for confident structural description, even at modest resolution, is demonstrated for N alpha A1,N epsilon B29-L,L-2,7-diaminosuberoyl (A2sb) insulin, a cross-linked insulin of low potency. The spatial arrangement of the cross-link itself can be described, and reliable estimates of the accuracy in atomic positions obtained. Comparison of invariant A2sb and native insulins shows a strong structural similarity, especially for the A chain surface residues and the dimer-forming residues of the B chain which have generally been strongly implicated in the receptor-binding region. Evidence from this analysis directs attention to the A chain, particularly the backbone, as being important in interactions with the membrane-bound receptor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7024090     DOI: 10.1515/bchm2.1981.362.1.755

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  11 in total

1.  Design of an active ultrastable single-chain insulin analog: synthesis, structure, and therapeutic implications.

Authors:  Qing-xin Hua; Satoe H Nakagawa; Wenhua Jia; Kun Huang; Nelson B Phillips; Shi-quan Hu; Michael A Weiss
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

2.  Inactive conformation of an insulin despite its wild-type sequence.

Authors:  G Kurapkat; E De Wolf; J Grötzinger; A Wollmer
Journal:  Protein Sci       Date:  1997-03       Impact factor: 6.725

3.  Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain.

Authors:  Satoe H Nakagawa; Ming Zhao; Qing-xin Hua; Shi-Quan Hu; Zhu-li Wan; Wenhua Jia; Michael A Weiss
Journal:  Biochemistry       Date:  2005-04-05       Impact factor: 3.162

4.  An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein.

Authors:  Michael D Glidden; Khadijah Aldabbagh; Nelson B Phillips; Kelley Carr; Yen-Shan Chen; Jonathan Whittaker; Manijeh Phillips; Nalinda P Wickramasinghe; Nischay Rege; Mamuni Swain; Yi Peng; Yanwu Yang; Michael C Lawrence; Vivien C Yee; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Biol Chem       Date:  2017-11-07       Impact factor: 5.157

5.  Solution structure of an ultra-stable single-chain insulin analog connects protein dynamics to a novel mechanism of receptor binding.

Authors:  Michael D Glidden; Yanwu Yang; Nicholas A Smith; Nelson B Phillips; Kelley Carr; Nalinda P Wickramasinghe; Faramarz Ismail-Beigi; Michael C Lawrence; Brian J Smith; Michael A Weiss
Journal:  J Biol Chem       Date:  2017-11-07       Impact factor: 5.157

6.  Comparative studies on the dynamics of crosslinked insulin.

Authors:  P Krüger; J Hahnen; A Wollmer
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

7.  Human insulin production from a novel mini-proinsulin which has high receptor-binding activity.

Authors:  S G Chang; D Y Kim; K D Choi; J M Shin; H C Shin
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

8.  Evidence concerning the mechanism of insulin-receptor interaction and the structure of the insulin receptor from biological properties of covalently linked insulin dimers.

Authors:  M A Tatnell; R H Jones; K P Willey; A Schüttler; D Brandenburg
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

9.  Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus.

Authors:  Q X Hua; S E Shoelson; K Inouye; M A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  A new interpretation of structure-function relationships in insulin-receptor interactions.

Authors:  D J Saunders
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.